Mg0003 50099 — San Francisco, California

Mg0003 50099 is a clinical research site located in San Francisco, California, United States 94117.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mg0003 50099 has participated in 1 clinical trials.

Therapeutic areas: Generalized Myasthenia Gravis.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mg0003 50099?

Mg0003 50099 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mg0003 50099 conducted?

Mg0003 50099 has 1 clinical trials on record. Their work covers Generalized Myasthenia Gravis.

Is Mg0003 50099 accredited by Crixeo Health?

Mg0003 50099 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mg0003 50099?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.